CG
BBH icon

Colony Group’s VanEck Biotech ETF BBH Stock Holding History

Colony Group’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-39,318
Closed -$4.9M – 499
2017
Q4 		$4.9M Buy
+39,318
New +$5.02M 0.31% 79
2017
Q1 		– Sell
-44,554
Closed -$4.79M – 273
2016
Q4 		$4.79M Buy
+44,554
New +$4.85M 0.51% 56
2016
Q1 		– Sell
-580
Closed -$74K – 278
2015
Q4 		$74K Buy
+580
New +$71.1K 0.01% 443

Other funds holding BBH

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
BRM
Boston Research & Management Manchester, Massachusetts $421M AUM 16.18% 1-Year Est. Return

Colony Group's BBH Position: Q1 2018 in Review

Colony Group sold out of VanEck Biotech ETF (BBH) in Q1 2018, closing a stake of 39,318 shares — an estimated $4.9M sold.

Colony Group first reported a position in BBH in Q4 2015 and held it in 3 quarters. The position peaked at $4.9M in Q4 2017. 82 funds tracked by Wall St. Rank hold BBH as of Q1 2018.

  • Colony Group reported no remaining VanEck Biotech ETF position as of Q1 2018 after selling out during the quarter.
  • Colony Group sold 39,318 VanEck Biotech ETF shares in Q1 2018, an estimated $4.9M.
  • Colony Group first reported a position in VanEck Biotech ETF in Q4 2015 and held it in 3 quarters.
  • Colony Group's VanEck Biotech ETF position peaked at $4.9M in Q4 2017.
  • 82 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2018.

Based on Colony Group's 13F filing for Q1 2018, filed 15 May 2018.